ArticleFrontiers in oral health2026
RACK1 and RPS6 as independent prognostic biomarkers in oral squamous cell carcinoma: a five-year survival analysis.
Article in Frontiers in oral health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: This study aimed to investigate the Clinicopathologic & prognostic significance of Receptor for Activated C Kinase 1 (RACK1) and Ribosomal Protein S6 (RPS6) in Oral Squamous Cell Carcinoma (OSCC) through immunohistochemistry. Methods: Formalin-fixed, paraffin-embedded tumor tissues of 100 OSCC cases who were treated primarily via surgery were retrieved and immunohistochemical analysis was done for RACK1 & RPS6. Clinicopathological data was gathered for these subjects and each was followed up for a period of 5 years from initial diagnosis. Association of expression of marker with clinicopathological parameters was done using Chi-square test. Prognostic significance was evaluated with Cox proportional hazards regression, Kaplan-Meier method, and receiver operating characteristic (ROC) analyses. Results: High expression of RACK1 and RPS6 was significantly associated with age ( Conclusion: The results of the present study suggest that RACK1 & RPS6 are associated with tumor progression and invasion in OSCC. Individual as well as combined expression of both the markers may be used as prognostic biomarker in OSCC for patient stratification and personalized treatment planning.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.